Posts by: Forest Ray

Forest Ray

Forest Ray received his PhD in systems biology from Columbia University, where he developed tools to match drug side effects to other diseases. He has since worked as a journalist and science writer, covering topics from rare diseases to the intersection between environmental science and social justice. He currently lives in Long Beach, California.

August 31, 2020August 31, 2020

Same But Different Photo Contest Celebrates People With Rare Diseases

News, syndicated

Same But Different, a U.K. nonprofit that uses the arts to bring communities together, is holding a calendar photography competition to raise awareness for rare diseases. Under the theme ... Read more

August 24, 2020August 24, 2020

Xperiome Platform Aims to Streamline Searches for Rare Diseases, Gain Patient Input

News, syndicated

Raremark, an online rare disease patient community, has launched a digital platform called Xperiome, aimed at streamlining the search for new medicines for rare disorders and incorporating more patient ... Read more

July 20, 2020July 20, 2020

New Molecule Shows Promise as Potential Cancer Vaccine for AML

News

Australian scientists have created a promising new vaccine candidate against cancers that express the Wilms’ tumor 1 (WT1) gene. These include cancers of the blood, like acute myeloid leukemia (AML), ... Read more

July 2, 2020July 2, 2020

Daurismo Combo Approved in Europe for Select Adults With AML

News

Pfizer announced that the European Commission has approved Daurismo (glasdegib) in combination with low-dose cytarabine to treat newly diagnosed acute myeloid leukemia (AML) among adults who are not candidates ... Read more

June 29, 2020June 30, 2020

FDA’s New ‘Project Patient Voice’ to Share Symptoms Data From Cancer Trials

News, syndicated

The U.S. Food and Drug Administration (FDA) has launched an initiative called Project Patient Voice to create a publicly available information bank describing patient-reported symptoms from cancer trials for ... Read more

June 22, 2020June 22, 2020

Genetic Testing Often Worth the Wait for More Tailored Treatments, Study Says

News

Waiting for the results of genetic tests to begin treatment for acute myeloid leukemia (AML) might allow certain patients to benefit from more tailored therapies, according to a recent ... Read more

June 15, 2020June 15, 2020

Moleculin Seeks Two More Test Sites in European Annamycin Trial

News

Despite disruptions from the COVID-19 pandemic, Moleculin Biotech is aiming to expand the number of sites for clinical trials of its annamycin chemotherapy for the treatment of acute myeloid ... Read more

June 10, 2020June 10, 2020

Coalition Will Address Racial Disparities in Rare Disease Communities

News

The Black Women’s Health Imperative (BWHI) recently created a Rare Disease Diversity Coalition focused on reducing racial disparities in the rare disease community. Getting a timely and accurate diagnosis ... Read more